Bevacizumab is an intravenous targeted medication used alone or in combination with other agents for the treatment of certain types of cancer.
Early side effects
Delayed side effects
Please seek medical attention if any of the following occurs:
Subcribe to our mailing list to get the updates to your email inbox...
Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.